Company profile for Standigm

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Standigm is an AI-driven drug discovery company. Applying its own innovative AI to the real world, Standigm currently has more than 20 preclinical pipelines across various therapeutic areas. Pursuing full-stack, AI-driven industrializing drug discovery, Standigm has achieved the automation of molecular design workflow through DarkMolFactory™, and the automation effort has been expanding to the whole drug discovery process on...
Standigm is an AI-driven drug discovery company. Applying its own innovative AI to the real world, Standigm currently has more than 20 preclinical pipelines across various therapeutic areas. Pursuing full-stack, AI-driven industrializing drug discovery, Standigm has achieved the automation of molecular design workflow through DarkMolFactory™, and the automation effort has been expanding to the whole drug discovery process on the basis of Standigm AI platforms, including Standigm ASK™ for target discovery, Standigm BEST™ for lead selection, and Standigm Insight™ for drug repurposing.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
Standigm, 3rd Floor, 70 Nonhyeon-ro 85-gil, Gangnam-gu, Seoul, 06234, Republic...
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/standigm-named-as-a-tech-innovator-in-generative-ai-in-drug-discovery-use-case-302018371.html

PR NEWSWIRE
19 Dec 2023

https://www.prnewswire.com/news-releases/standigm-and-nashville-biosciences-join-to-revolutionize-early-drug-discovery-301897580.html

PR NEWSWIRE
10 Aug 2023

https://www.prnewswire.com/news-releases/standigm-announces-younsung-choo-as-chief-executive-officer-301794874.html

PR NEWSWIRE
12 Apr 2023

http://www.pharmabiz.com/NewsDetails.aspx?aid=154543&sid=2

PHARMABIZ
18 Nov 2022

https://www.prnewswire.com/news-releases/standigm-synthetic-research-center-successfully-accelerates-drug-discovery-in-its-first-year-301680824.html

PRNEWSWIRE
16 Nov 2022
Standigm To Attend Bio-Europe® 2022
Standigm To Attend Bio-Europe® 2022

18 Oct 2022

// PRNEWSWIRE

https://www.prnewswire.com/news-releases/standigm-to-attend-bio-europe-2022-301652575.html

PRNEWSWIRE
18 Oct 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty